An AllTrials project

NCT03235050: A reported trial by AstraZeneca

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT03235050
Title A Phase IIb, Randomised, Parallel, Double-Blind Placebo-Controlled and Open-Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes Mellitus
Results Status Reported
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Aug. 2, 2017
Completion date May 3, 2018
Required reporting date May 3, 2021, midnight
Actual reporting date June 3, 2020
Date last checked at ClinicalTrials.gov May 11, 2022
Days late None